Pricing
  1. JP-listed companies
  2. Euglena Co., Ltd.
  3. Financials
  4. Cost of revenue

Euglena Co., Ltd. (2931)

Market cap
¥57.8B
P/E ratio
Develops health foods, cosmetics, and biofuels using Euglena microalgae through proprietary large-scale cultivation technology across healthcare and sustainable energy markets.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCost of revenue (Million JPY)YoY (%)
Dec 31, 202515,336+6.87%
Dec 31, 202414,350-2.43%
Dec 31, 202314,707+9.79%
Dec 31, 202213,396+3.44%
Dec 31, 202112,951+56.25%
Sep 30, 20218,289+116.69%
Sep 30, 20203,825-4.61%
Sep 30, 20194,010-4.98%
Sep 30, 20184,220+14.76%
Sep 30, 20173,678+23.97%
Sep 30, 20162,966+55.72%
Sep 30, 20151,905+59.06%
Sep 30, 20141,198

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat